Skip to main content
Premium Trial:

Request an Annual Quote

GenapSys Raises $70M in Series D Financing

NEW YORK – Sequencing technology developer GenapSys said on Thursday that it has raised $70 million in Series D equity financing. The firm is also expanding its board of directors.

Farallon Capital Management and Soleus Capital led the round, joined by additional new investors who were not disclosed.

In a statement, GenapSys said it will use the proceed to further develop its semiconductor-based next-generation sequencing platform. CEO Jason Myers added that the firm would accelerate development of new products, particularly in oncology.

The Redwood City, California-based firm has now raised at least $236 million since 2013, plus $75 million in debt funding last year. The firm offers its benchtop GenapSys Sequencer and a library preparation instrument.

GenapSys is adding Bob Zollars, senior adviser at Frazier Healthcare Partners, and a representative of Farallon Capital to its board. Zollars was previously group president at Cardinal Health. He is also chair of the trustees of Arizona State University.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.